Clicky

Interpace Diagnostics Group, Inc.(IDXG)

Description: PDI, Inc. provides outsourced commercial services to pharmaceutical, biotechnology, diagnostics, and healthcare companies in the United States. It operates in two segments, Commercial Services and Interpace Diagnostics. The Commercial Services segment offers outsourced sales teams that target healthcare providers, providing a range of complementary sales support services designed to achieve its customers' strategic and financial product objectives. This segment offers a range of personal and non-personal promotional options for the commercialization of their products throughout the product lifecycles, from development through maturity. It also provides other promotional services, including clinical educator, teledetailing, and full product commercialization services. This segment's services include product distribution, personal and non-personal product detailing, full supply chain management, operations, sales, marketing, compliance, and regulatory/medical management. The Interpace Diagnostics segment focuses on developing and commercializing molecular diagnostic tests for physicians and patients with diagnostic options for detecting genetic and other molecular alterations associated with gastrointestinal and endocrine cancers. This segment offers PancraGen, a diagnostic test designed for determining risk of malignancy in pancreatic cysts; and ThyGenX, a next-generation sequencing test designed to assist physicians in distinguishing between benign and malignant genotypes in indeterminate thyroid nodules. It also has three diagnostic tests in late stage development that are designed to detect genetic alterations that are associated with gastrointestinal cancers; and one diagnostic test in late stage development that is designed to detect genetic alterations that are associated with endocrine cancers. PDI, Inc. was incorporated in 1986 and is headquartered in Parsippany, New Jersey.


Keywords: Biotechnology Cancer Life Sciences Biology Supply Chain Management Healthcare Providers Diagnostic Tests Medical Genetics Gastrointestinal Thyroid Product Lifecycle Qiagen Promotional Services Genotype Gastrointestinal Cancer Medical Management Gastrointestinal Cancers Thyroid Nodule Thyroid Nodules

Home Page: www.interpace.com

IDXG Technical Analysis

Morris Corporate Center 1
Parsippany, NJ 07054
United States
Phone: 855 776 6419


Officers

Name Title
Dr. Thomas W. Burnell Ph.D. Pres, CEO & Director
Mr. Thomas John Freeburg Ph.D. Principal Financial Officer
Dr. Sydney D. Finkelstein Chief Scientific Officer
Ms. Susanne P. Reilly Ph.D. Chief HR Officer
Mr. Jody Campbell Chief Revenue Officer
Mr. Patrick Kane VP & Corp. Controller

Exchange: OTCQX

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 10.0372
Price-to-Sales TTM: 0.1024
IPO Date: 1998-05-20
Fiscal Year End: December
Full Time Employees: 147
Back to stocks